| Dr Charlotte Morgan Meadows, MD | |
|
21 Hughes Rd Ste 2, Madison, AL 35758-3040 | |
| (256) 772-2037 | |
| (256) 772-9523 |
| Full Name | Dr Charlotte Morgan Meadows |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 21 Hughes Rd Ste 2, Madison, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871531822 | NPI | - | NPPES |
| 051001843 | Other | AL | BLUE CROSS & BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 26583 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charlotte Morgan Meadows, MD 21 Hughes Road, Suite 2, Madison, AL 35758-3040 Ph: (256) 772-2037 | Dr Charlotte Morgan Meadows, MD 21 Hughes Rd Ste 2, Madison, AL 35758-3040 Ph: (256) 772-2037 |
News Archive
A NEW simple procedure which involves gently scratching the lining of the womb in the month before IVF treatment, potentially improving treatment success, is being tested on first-time IVF attempters in a groundbreaking study.
KAEL-GemVax, a leading oncology biopharmaceutical company, today announced that it had been officially notified by the independent Data Monitoring Committee that over 1000 patients have been enrolled in the TeloVac Study, making it the world's largest ever pancreatic cancer vaccine trial.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
The chances are your working environment today is a far more complex place than it was 20 years ago.
Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading.
› Verified 7 days ago
Dr. Jitendra A Jain, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 102 Essex Ct, Ste A, Madison, AL 35758 Phone: 256-461-8442 Fax: 256-461-8447 | |
Dr. Jeffrey D Brassart, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 Will Halsey Way, Madison, AL 35758 Phone: 256-461-7440 Fax: 256-461-7168 | |
Dr. Marc Alan Hultquist, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12205 County Line Rd Ste C, Madison, AL 35758 Phone: 256-258-8319 Fax: 256-489-4070 | |
Dr. Patricia Gissendanner Moody, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 Hughes Rd, Suite 2500, Madison, AL 35758 Phone: 256-772-2037 Fax: 256-772-9523 | |
Dr. Elizabeth Maguire Bryant, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 21 Hughes Road, Suite 2, Madison, AL 35758 Phone: 256-772-2037 Fax: 256-772-9523 | |
Dr. Cynthia J Dill, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 21 Hughes Rd, Suite 2, Madison, AL 35758 Phone: 256-772-2037 Fax: 256-772-9523 | |
Dr. Kevin Scott Denny, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 Will Halsey Way, Madison, AL 35758 Phone: 256-461-7440 Fax: 256-461-7168 |